US Patent Issued to NATIONAL CANCER CENTER, RIN INSTITUTE on Dec. 30 for "Fusion protein suitable for dissolving fibrin clot, and pharmaceutical composition containing said fusion protein" (Japanese Inventors)

ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,509,507, issued on Dec. 30, was assigned to NATIONAL CANCER CENTER (Tokyo) and RIN INSTITUTE INC. (Tokyo).

"Fusion protein suitable for dissolving fibrin clot, and pharmaceutical composition containing said fusion protein" was invented by Yasuhiro Matsumura (Chiba, Japan), Shingo Hanaoka (Chiba, Japan) and Shinji Saijo (Chiba, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a fusion protein suitable for dissolving a fibrin clot and a pharmaceutical composition containing the fusion protein. According to the present invention, there is provided a fusion protein of an antibody that binds to insoluble fibrin or an antige...